BML‐190 and AM251 act as inverse agonists at the human cannabinoid CB2 receptor: signalling via cAMP and inositol phosphates
@article{New2003BML190AA, title={BML‐190 and AM251 act as inverse agonists at the human cannabinoid CB2 receptor: signalling via cAMP and inositol phosphates}, author={David C. New and Yung H. Wong}, journal={FEBS Letters}, year={2003}, volume={536} }
31 Citations
Modulation of P‐glycoprotein activity by cannabinoid molecules in HK‐2 renal cells
- Biology, ChemistryBritish journal of pharmacology
- 2006
The present data provide the first evidence that the endocannabinoid AEA and different synthetic cannabinoids may inhibit the P‐gp activity in vitro via a cannabinoid receptor‐independent mechanism.
Pharmacological actions of cannabinoids.
- Biology, ChemistryHandbook of experimental pharmacology
- 2005
More information is beginning to emerge about the pharmacological actions of the non-psychoactive plant cannabinoid, cannabidiol, as well as acting on CB1 and CB2 receptors, and there is convincing evidence that anandamide can activate transient receptor potential vanilloid type 1 (TRPV1) receptors.
Tetrahydrocannabinol‐induced neurotoxicity depends on CB1 receptor‐mediated c‐Jun N‐terminal kinase activation in cultured cortical neurons
- BiologyBritish journal of pharmacology
- 2003
It is reported that THC induces the activation of JNK via the CB1 receptor and its associated G‐protein, Gi/o.n‐terminal kinase, central to the THC‐induced activation of the apoptotic pathway in cortical neurons.
In vitro metabolism of indomethacin morpholinylamide (BML-190), an inverse agonist for the peripheral cannabinoid receptor (CB(2)) in rat liver microsomes.
- Biology, ChemistryEuropean journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
- 2010
The inhibitory action of exo- and endocannabinoids on [3H]GABA release are mediated by both CB1 and CB2 receptors in the mouse hippocampus
- Biology, ChemistryNeurochemistry International
- 2012
Functional CB2 type cannabinoid receptors at CNS synapses
- Biology, ChemistryNeuropharmacology
- 2009
Role for Cannabinoid Receptors in Human Proximal Tubular Hypertrophy
- Biology, MedicineCellular Physiology and Biochemistry
- 2010
A role for cannabinoid receptors in proximal tubule cells is identified which may provide novel therapeutic targets for the treatment of diabetes and obesity.
Detecting constitutive activity and protean agonism at cannabinoid-2 receptor.
- BiologyMethods in enzymology
- 2010
Expression of functional CB1 cannabinoid receptors in retinoic acid‐differentiated P19 embryonal carcinoma cells
- BiologyJournal of neuroscience research
- 2006
The protocol used provides an in vitro model system expressing CB1 cannabinoid receptors at the level of mRNA, protein, and AM251‐sensitive agonist‐induced inhibition of intracellular cyclic AMP accumulation, which may be useful to investigate the developmental regulation, expression and function of neuronal cannabinoid receptors.
Characterization of human cannabinoid CB2 receptor coupled to chimeric Galpha(qi5) and Galpha(qo5) proteins.
- BiologyEuropean journal of pharmacology
- 2009
References
SHOWING 1-10 OF 26 REFERENCES
Agonist‐inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656 and AM630
- Biology, ChemistryBritish journal of pharmacology
- 1999
It is concluded that AM630 is a CB2‐selective ligand that behaves as an inverse agonist at CB2 receptors and as a weak partial agonists at CB1 receptors.
SR 144528, an antagonist for the peripheral cannabinoid receptor that behaves as an inverse agonist.
- BiologyThe Journal of pharmacology and experimental therapeutics
- 1999
These data provide evidences for the inverse agonist property of SR 144528 and the constitutive activation of CB2 in Chinese hamster ovary-expressing cells.
Pharmacology of cannabinoid CB1 and CB2 receptors.
- Biology, MedicinePharmacology & therapeutics
- 1997
Autocrine and paracrine regulation of lymphocyte CB2 receptor expression by TGF-beta.
- Biology, MedicineBiochemical and biophysical research communications
- 2002
One mechanism by which marijuana-derived cannabinoid Delta(9)-tetrahydrocannabinol contributes to immune suppression is by stimulating an enhanced production of lymphocyte TGF-beta, according to the data.
In vitro and in vivo pharmacological characterization of JTE-907, a novel selective ligand for cannabinoid CB2 receptor.
- Biology, ChemistryThe Journal of pharmacology and experimental therapeutics
- 2001
This is the first report that a CB2-selective inverse agonist, JTE-907, has an anti-inflammatory effect in vivo, and how the inverse agonists showed the same effect as Win55212-2 and Delta(9)-THC is discussed.
Pharmacology of cannabinoid receptor ligands.
- Biology, ChemistryCurrent medicinal chemistry
- 1999
This review summarizes current knowledge about the in vitro pharmacological properties of important CB1 and CB2 receptor ligands and pays particular attention to the binding properties of these ligands, to the efficacies of cannabinoid receptor agonists, as determined using cyclic AMP or [35S]GTPgammaS binding assays, and to selected examples of how these pharmacological Properties can be influenced by chemical structure.
International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
- BiologyPharmacological Reviews
- 2002
It is considered premature to rename cannabinoid receptors after an endogenous agonist as is recommended by the International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification, because pharmacological evidence for the existence of additional types of cannabinoid receptor is emerging and other kinds of supporting evidence are still lacking.
Activation of the human peripheral cannabinoid receptor results in inhibition of adenylyl cyclase.
- Biology, ChemistryMolecular pharmacology
- 1995
The results demonstrate that the CB2 receptor is functionally coupled to inhibition of adenylyl cyclase activity via a pertussis toxin-sensitive G protein.
Mutation of a highly conserved aspartate residue in the second transmembrane domain of the cannabinoid receptors, CB1 and CB2, disrupts G-protein coupling.
- Biology, ChemistryThe Journal of pharmacology and experimental therapeutics
- 1998
The data suggest that this aspartate residue is not generally important for ligand recognition in the cannabinoid receptors; however, it is required for communication with G proteins and signal transduction.
Δ9-Tetrahydrocannabinol regulates Th1/Th2 cytokine balance in activated human T cells
- Biology, MedicineJournal of Neuroimmunology
- 2002